Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Tax Rate (2023 - 2025)

Protalix BioTherapeutics has reported Tax Rate over the past 3 years, most recently at 459.39% for Q4 2025.

  • Quarterly results put Tax Rate at 459.39% for Q4 2025, down 46433.0% from a year ago — trailing twelve months through Dec 2025 was 108.26% (down 11959.0% YoY), and the annual figure for FY2025 was 96.79%, down 10812.0%.
  • Tax Rate for Q4 2025 was 459.39% at Protalix BioTherapeutics, down from 7.82% in the prior quarter.
  • Over the last five years, Tax Rate for PLX hit a ceiling of 75.19% in Q2 2025 and a floor of 459.39% in Q4 2025.
  • Median Tax Rate over the past 3 years was 2.97% (2024), compared with a mean of 29.95%.
  • Peak annual rise in Tax Rate hit 7215bps in 2025, while the deepest fall reached -46433bps in 2025.
  • Protalix BioTherapeutics' Tax Rate stood at 15.75% in 2023, then crashed by -69bps to 4.94% in 2024, then tumbled by -9401bps to 459.39% in 2025.
  • The last three reported values for Tax Rate were 459.39% (Q4 2025), 7.82% (Q3 2025), and 75.19% (Q2 2025) per Business Quant data.